Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Stem cells show potential to restore fertility after chemotherapy

26 October 2015

By Dr Nicoletta Charolidi

Appeared in BioNews 825

A stem-cell therapy in mice shows promise for reversing infertility in women who have received cancer treatment.

Researchers from Mansoura Medical School in Egypt and Georgia Medical School in Augusta showed that human bone marrow mesenchymal stem cells injected directly into mouse ovaries after chemotherapy were able to repair damage to the reproductive tissue and restore fertility.

The work was presented at the 71st Annual Meeting of the American Society for Reproductive Medicine (ASRM) in Baltimore last week.

The mice that received the stem-cell treatment regained oestrogen production as early as one week after the injection. Blood profiling revealed a restored ovarian function and an increase in the number and size of follicles. These mice went on to have pups in litter sizes comparable to those from mice that did not receive chemotherapy.

The toxicity of chemotherapy can permanently damage the ovaries and egg reserve in women of fertile age. Unlike men, who produce sperm throughout their life, women are born with all their eggs and, if destroyed, infertility and early menopause can occur. More than 20,000 women of childbearing age are diagnosed with cancer each year in the UK.

Current practice offers women the option to receive egg stimulation and cryopreservation, but there is not always enough time for this between cancer diagnosis and chemotherapy treatment.

Dr Owen Davis, the elected president of ASRM, said, 'If this experimental treatment can be translated to women who have lost ovarian function from chemotherapy, it will be a great advance.

'Restoring ovarian hormone production, follicle development and fertility to chemotherapy patients is a potential new application for bone marrow donation that could help many women'.

If it proves safe for use in humans, stem cell ovarian regeneration could also potentially treat other causes of infertility and early menopause.

Consultant gynaecologist Dr Stuart Lavery, of Imperial College London, told the Telegraph: 'This is a very exciting piece of research that adds to our understanding of how cells differentiate to become egg stem cells.

'There remains an enormous amount of work to see if these results would be transferable into humans, but it does provide realistic hope that post-chemotherapy patients could restore ovarian function and possibly fertility.'

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

11 September 2017 - by Dr Katie Howe 
An existing drug has been shown to protect eggs from radiation and chemotherapy damage in research carried out in mice...
25 July 2016 - by Dr Katie Howe 
Researchers in Greece have used a blood treatment to rejuvenate the ovaries of post-menopausal women, enabling them to restart their periods and produce fertile eggs...
11 July 2016 - by Dr Rosie Gilchrist 
A two-year-old girl has become the youngest person to undergo a new technique that could preserve her fertility after chemotherapy...
11 April 2016 - by Dr Edgar Mocanu 
Oncofertility services allow some women to cryopreserve oocytes, embryos or ovarian tissue in order to protect their ability to have a family when faced with malignancy and adjuvant therapy. However, to date, fertility cryopreservation had very little to offer young, pre-pubertal girls...
07 March 2016 - by Dr Dusko Ilic 
A recent announcement that scientists had created functioning spermatozoids from mouse embryonic stem cells in the lab made quite a splash in the media. However, one key point seemed to be overlooked...

12 October 2015 - by Dr Rachel Brown 
A Danish study has reported that ovarian tissue transplants appear to be safe and can restore fertility in women who have undergone treatment for cancer, with around one in three procedures in young women leading to live births....
05 October 2015 - by Dr Nicola Davis 
A genetic test that can identify women with early-stage breast cancer who can be spared unnecessary treatment with chemotherapy has been shown to be effective in a clinical study...
01 September 2015 - by Kirsty Oswald 
Researchers in the USA have found that fertility concerns may be contributing to low tamoxifen use and discontinuation of the drug among reproductive-age breast cancer patients...
24 August 2015 - by Dr Edgar Mocanu 
How easy is to tell a 25-year-old that she has no eggs and that she may never have a family using her own oocytes...
10 August 2015 - by Dr Rosie Gilchrist 
Adolescents or young adults with cancer may not be aware of available options to preserve their fertility, according to a study published in the journal Cancer...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation